Shanghai Henlius Biotech, Inc. (2696.HK) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending approval ...

Researchers from the universities of Zurich, Yale and Harvard reveal the differences between the characteristics of the ...

In a recent transaction, Sheena Jonathan, Co-Founder of Natera, Inc. (NASDAQ: NTRA), a leader in personalized genetic testing and diagnostics, sold a significant amount of company ...

For patients with metastatic renal cell carcinoma (mRCC) and progression during or after one to two prior lines of therapy, ...

Disease-free survival is significantly longer with adjuvant pembrolizumab than observation among patients with high-risk ...

SAINT study is currently investigating intravenous trabectedin plus ipilimumab and nivolumab in the first line for advanced ...

Hello Health Rounds Readers! Today we feature two early studies that might turn out to be laying the groundwork for some paradigm-changing advances. One study suggests it might someday be possible to ...

Researchers have used a drug screening platform they developed to show that an antidepressant, currently on the market, kills tumor cells in the dreaded glioblastoma -- at least in the cell-culture ...

FDA approves Lilly's eczema drug, Ebglyss, and the expanded use of Novartis' Kisqali, Merck's Keytruda and AstraZeneca's Fasenra.

NKT2152, a novel HIF2a inhibitor, demonstrates significant efficacy in patients with advanced clear cell renal cell carcinoma ...